Kiora Pharmaceuticals, Inc.
KPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $2 | $6 | $8 |
| Short-Term Investments | $23 | $0 | $0 | $0 |
| Receivables | $1 | $2 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $0 | $0 | $1 |
| Total Curr. Assets | $30 | $5 | $8 | $9 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $9 | $11 | $11 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $0 | $0 | $0 |
| Total NC Assets | $7 | $9 | $11 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $36 | $14 | $19 | $20 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $1 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $1 | $2 | $1 |
| Total Curr. Liab. | $6 | $2 | $3 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $1 | $1 | $1 |
| Other NC Liab. | $5 | $5 | $3 | $3 |
| Total NC Liab. | $5 | $6 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $11 | $8 | $7 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$143 | -$147 | -$134 | -$121 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $169 | $153 | $146 | $136 |
| Total Equity | $26 | $6 | $11 | $15 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $36 | $14 | $19 | $20 |
| Net Debt | -$4 | -$2 | -$6 | -$8 |